Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

作者：Shengli Xia, Yuntao Zhang, Yanxia Wang, Hui Wang, Yunkai Yang, George F. Gao, Wenjie Tan, Guizhen Wu, Miao Xu, Zhiyong Lou, Weijin Huang, Wenbo Xu, Baoying Huang, Wei Wang, Wei Zhang, Na Li, Zhiqiang Xie, Xiujuan Zhu, Ling Ding, Wangyang You, Yuxiu Zhao, Jun Zhao, Lili Huang, Xuezhong Shi, Yongli Yang, Guangxue Xu, WenLing Wang, Peipei Liu, Meng Ma, YuLing Qiao, Suhua Zhao, Jingjing Chai, QinQin Li, Hui Fu, Ying Xu, Xiaotong Zheng, Wanshen Guo, Xiaoming Yang · 发表于：The Lancet Infectious Diseases · 年份：2021 · DOI：10.1016/s1473-3099(21)00462-x · 被引用次数：202 · 研究领域：SARS-CoV-2 and COVID-19 Research、vaccines and immunoinformatics approaches、Immune responses and vaccinations